Y-Intercept (HK)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-54,813
| Closed | -$745K | – | 1710 |
|
|
2025
Q1 | $745K | Buy |
54,813
+18,807
| +52% | +$256K | 0.05% | 526 |
|
|
2024
Q4 | $734K | Buy |
36,006
+22,183
| +160% | +$452K | 0.05% | 558 |
|
|
2024
Q3 | $403K | Sell |
13,823
-25,369
| -65% | -$739K | 0.02% | 881 |
|
|
2024
Q2 | $910K | Buy |
+39,192
| New | +$910K | 0.05% | 534 |
|
|
2023
Q4 | – | Sell |
-26,618
| Closed | -$549K | – | 1322 |
|
|
2023
Q3 | $549K | Buy |
+26,618
| New | +$549K | 0.05% | 532 |
|
|
2021
Q2 | – | Sell |
-4,886
| Closed | -$265K | – | 682 |
|
|
2021
Q1 | $265K | Buy |
+4,886
| New | +$265K | 0.07% | 457 |
|